Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma.

Cancer science - 1 Sept 2020

Baba Yoshifumi, Nomoto Daichi, Okadome Kazuo, Ishimoto Takatsugu, Iwatsuki Masaaki, Miyamoto Yuji, Yoshida Naoya, Baba Hideo

Abstract excerpt

Esophageal squamous cell carcinoma (ESCC) is the main prevalent histological type of esophageal cancer, predominantly constituting 90% of cases worldwide. Despite the development of multidisciplinary therapeutic approaches, its prognosis remains unfavorable. Recently, the development of monoclonal antibodies inhibiting programmed death 1 (PD-1) or programmed death-ligand 1 (PD-L1) has led to marked therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Esophageal Neoplasms

Share to Esophageal Squamous Cell Carcinoma

Share to Immunomodulation

Share to Killer Cells, Natural

Share to Lymphocytes, Tumor-Infiltrating

Share to Myeloid-Derived Suppressor Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 32579769
DOI: 10.1111/cas.14541
PMCID: PMC7469863

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma.PMID 32579769Read ↗

Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinomaSemantic proximity Read ↗

Tumor microenvironment distinctions between esophageal cancer subtypes explain varied immunotherapy responsesSemantic proximity Read ↗

Identification of a novel signature based on T cell-related genes to explore prognosis and immune microenvironment in esophageal squamous carcinomaSemantic proximity Read ↗

Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal CancerSemantic proximity Read ↗

Molecular Biology and Clinical Management of Esophageal AdenocarcinomaSemantic proximity Read ↗

Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.Semantic proximity Read ↗

Identification of a prognostic immune signature for esophageal squamous cell carcinoma to predict survival and inflammatory landscapesSemantic proximity Read ↗

Single cell sequencing revealed the mechanism of PD-1 resistance affected by the expression profile of peripheral blood immune cells in ESCCSemantic proximity Read ↗

Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: Implications for immunotherapySemantic proximity Read ↗

Immune cell‐related prognostic risk model and tumor immune environment modulation in esophageal carcinoma based on single‐cell and bulk RNA sequencingSemantic proximity Read ↗

Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.Semantic proximity Read ↗

Mining genes related to microenvironment of esophageal squamous cell carcinoma based on TCGA databaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.